In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT

Published:2011-04-04 Issue:1 Volume:47 Page:101-106
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Dominietto A,Tedone E,Soracco M,Bruno B,Raiola A M,Van Lint M T,Geroldi S,Lamparelli T,Galano B,Gualandi F,Frassoni F,Bacigalupo A

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt201128.pdf

Reference21 articles.

1. Opelz G, Daniel V, Naujokat C, Fickenscher H, Döhler B . Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis. Lancet Oncol 2007; 8: 212–218.

2. Van Esser JW, van der Holt B, Meijer E, Niesters HG, Trenschel R, Thijsen SF et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and qualitatively predicts EBV-lymphoproliferative disease following T cell depleted SCT. Blood 2001; 98: 972–978.

3. Orazi A, Hromas RA, Neiman RS, Greiner TC, Lee CH, Rubin L et al. Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features. Am J Clin Pathol 1997; 107: 419–429.

4. Landgren O, Gilbert ES, Rizzo JD, Socié G, Banks PM, Sobocinski KA et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood 2009; 113: 4992–5001.

5. Meijer E, Cornelissen JJ . Virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients. Curr Opin Hematol 2008; 15: 576–585.

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT Outcomes;Viruses;2024-08-14

2. Impact of prophylaxis with rituximab on EBV-related complications after allogeneic hematopoietic cell transplantation in children;Frontiers in Immunology;2024-07-11

3. Efficacy and safety of outpatient fludarabine, cyclophosphamide, and rituximab based allogeneic hematopoietic cell transplantation in adults with severe aplastic anemia;Bone Marrow Transplantation;2024-06-15

4. Advances and prospect in herpesviruses infections after haematopoietic cell transplantation: closer to the finish line?;Clinical Microbiology and Infection;2024-06

5. Epstein-Barr Virus: Acute Infection, Oncogenesis, Prevention and Pitfalls;Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3